American venture capitalists funded a company that grows customized organs in 3 months.
Traditional organ printing takes months. American biotech accelerated the process using bioreactor technology and growth factor optimization. Customized organs—liver, kidney, pancreas, heart—are grown from your cells in 3 months. Transplant waiting lists disappear.
The organ transplant industry makes billions from scarcity. If organs are available in 3 months, the entire transplant system collapses. So American breakthrough is prevented from scaling while people die on transplant lists. The system profits from organ scarcity.
Picture the organ failure patient who needs a transplant. Instead of waiting years on a list, a customized organ is grown in 3 months. Picture transplant lists eliminated. Picture everyone who needs an organ getting one. American biotech has this technology. The transplant industry is preventing it because organ scarcity is their power.
Why must people die on transplant lists when America can grow organs in 3 months?
Source: Stanford Bioengineering, Nature Biotechnology 2026
Geen opmerkingen:
Een reactie posten